Size mismatch in liver transplantation

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 23, Issue 8, 2016, Pages 457-466

  Fukazawa, Kyota ^a   Nishida, Seigo ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Graft outcome; Graft weight to recipient body weight ratio; Large for size; Size mismatch; Small for size; Standard liver volume

Indexed keywords

OCTREOTIDE; SOMATOSTATIN; TERLIPRESSIN; THROMBOMODULIN;

ANALYTIC METHOD; BODY WEIGHT; CADAVER DONOR; DISEASE EXACERBATION; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATORENAL SYNDROME; HUMAN; LIVER GRAFT; LIVER INJURY; LIVER ISCHEMIA; LIVER RESECTION; LIVER SIZE; LIVER SIZE MISMATCH; LIVER TRANSPLANTATION; LIVING DONOR; MEASUREMENT ACCURACY; METABOLIC PARAMETERS; MORBIDITY; NONHUMAN; OUTCOME ASSESSMENT; PATIENT MONITORING; PATIENT SAFETY; PORTAL HYPERTENSION; POSTOPERATIVE COMPLICATION; PROFESSIONAL KNOWLEDGE; REPERFUSION INJURY; REVIEW; VEIN CATHETERIZATION; WELLBEING;

EID: 84982266715     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1002/jhbp.371     Document Type: Review

References (90)

1. Emond JC, Renz JF, Ferrell LD, Rosenthal P, Lim RC, Roberts JP, et al. Functional analysis of grafts from living donors. Implications for the treatment of older recipients. Ann Surg. 1996;224:544–52.
2. Shirakata Y, Terajima H, Mashima S, Inomoto T, Nishizawa F, Saad S, et al. The minimum graft size for successful orthotopic partial liver transplantation in the canine model. Transplant Proc. 1995;27:545–6.
3. Marchioro TL, Porter KA, Brown BI, Otte JB, Starzl TE. The effect of partial portacaval transposition on the canine liver. Surgery. 1967;61:723–32.
4. Ito T, Kiuchi T, Yamamoto H, Oike F, Ogura Y, Fujimoto Y, et al. Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications. Transplantation. 2003;75:1313–7.
5. Kelly DM, Demetris AJ, Fung JJ, Marcos A, Zhu Y, Subbotin V, et al. Porcine partial liver transplantation: a novel model of the “small-for-size” liver graft. Liver Transpl. 2004;10:253–63.
6. Man K, Lo CM, Ng IO, Wong YC, Qin LF, Fan ST, et al. Liver transplantation in rats using small-for-size grafts: a study of hemodynamic and morphological changes. Arch Surg. 2001;136:280–5.
7. Monbaliu D, van Pelt J, De Vos R, Greenwood J, Parkkinen J, Crabbe T, et al. Primary graft nonfunction and Kupffer cell activation after liver transplantation from non-heart-beating donors in pigs. Liver Transpl. 2007;13:239–47.
8. Fukumori T, Ohkohchi N, Tsukamoto S, Satomi S. The mechanism of injury in a steatotic liver graft during cold preservation. Transplantation. 1999;67:195–200.
9. Selzner M, Rudiger HA, Sindram D, Madden J, Clavien PA. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology. 2000;32:1280–8.
10. Hatsugai K, Ohkohchi N, Fukumori T, Akamatsu Y, Satomi S. Mechanism of primary graft non-function in a rat model for fatty liver transplantation. Transpl Int. 2000;13(Suppl 1):S583–S590.
11. Garcia-Valdecasas JC, Fuster J, Charco R, Bombuy E, Fondevila C, Ferrer J, et al. Changes in portal vein flow after adult living-donor liver transplantation: does it influence postoperative liver function? Liver Transpl. 2003;9:564–9.
12. Soejima Y, Taketomi A, Yoshizumi T, Uchiyama H, Harada N, Ijichi H, et al. Feasibility of left lobe living donor liver transplantation between adults: an 8-year, single-center experience of 107 cases. Am J Transplant. 2006;6(5 Pt 1):1004–11.
13. Kato Y, Shimazu M, Wakabayashi G, Tanabe M, Morikawa Y, Hoshino K, et al. Significance of portal venous flow in graft regeneration after living related liver transplantation. Transplant Proc. 2001;33:1484–5.
14. Panis Y, McMullan DM, Emond JC. Progressive necrosis after hepatectomy and the pathophysiology of liver failure after massive resection. Surgery. 1997;121:142–9.
15. Kiuchi T, Onishi Y, Nakamura T. Small-for-size graft: not defined solely by being small for size. Liver Transpl. 2010;16:815–7.
16. Tanaka A, Tanaka K, Tokuka A, Kitai T, Shinohara H, Hatano E, et al. Graft size-matching in living related partial liver transplantation in relation to tissue oxygenation and metabolic capacity. Transpl Int. 1996;9:15–22.
17. Fukazawa K, Nishida S, Volsky A, Tzakis AG, Pretto EA Jr. Body surface area index predicts outcome in orthotopic liver transplantation. J Hepatobiliary Pancreat Sci. 2011;18:216–25.
18. Fukazawa K, Yamada Y, Nishida S, Hibi T, Arheart KL, Pretto EA Jr. Determination of the safe range of graft size mismatch using body surface area index in deceased liver transplantation. Transpl Int. 2013;26:724–33.
19. Kiuchi T, Kasahara M, Uryuhara K, Inomata Y, Uemoto S, Asonuma K, et al. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation. 1999;67:321–7.
20. Dahm F, Georgiev P, Clavien PA. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant. 2005;5:2605–10.
21. Heaton N. Small-for-size liver syndrome after auxiliary and split liver transplantation: donor selection. Liver Transpl. 2003;9:S26–8.
22. Moriyasu F, Ban N, Nishida O, Nakamura T, Miyake T, Uchino H, et al. Clinical application of an ultrasonic duplex system in the quantitative measurement of portal blood flow. J Clin Ultrasound. 1986;14:579–88.
23. Rangel Moreira Dde A, Aoun Tannuri AC, Belon AR, Mendonca Coelho MC, Oliveira Goncalves J, Serafini S, et al. Large-for-size liver transplantation: a flowmetry study in pigs. J Surg Res. 2014;189:313–20.
24. Shimada M, Fujii M, Morine Y, Imura S, Ikemoto T, Ishibashi H. Living-donor liver transplantation: present status and future perspective. J Med Invest. 2005;52:22–32.
25. Xu HS, Pruett TL, Jones RS. Study of donor-recipient liver size match for transplantation. Ann Surg. 1994;219:46–50.
26. Levesque E, Duclos J, Ciacio O, Adam R, Castaing D, Vibert E. Influence of larger graft weight to recipient weight on the post-liver transplantation course. Clin Transplant. 2013;27:239–47.
27. Akdur A, Kirnap M, Ozcay F, Sezgin A, Ayvazoglu Soy HE, Karakayali Yarbug F, et al. Large-for-size liver transplant: a single-center experience. Exp Clin Transplant. 2015;13(Suppl 1):108–10.
28. Hastie T, Tibshirani R. Generalized additive models for medical research. Stat Methods Med Res. 1995;4:187–196.
29. Hastie T, Tibshirani R. Generalized additive models. Stat Sci. 1986;1:297–310.
30. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359:1018–26.
31. Aviles RJ, Askari AT, Lindahl B, Wallentin L, Jia G, Ohman EM, et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med. 2002;346:2047–52.
32. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med. 2010;362:217–27.
33. Urata K, Kawasaki S, Matsunami H, Hashikura Y, Ikegami T, Ishizone S, et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology. 1995;21:1317–21.
34. Rinella ME, Alonso E, Rao S, Whitington P, Fryer J, Abecassis M, et al. Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl. 2001;7:409–14.
35. Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charnsangavej C, et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery. 2000;127:512–9.
36. Abdalla EK, Denys A, Chevalier P, Nemr RA, Vauthey JN. Total and segmental liver volume variations: implications for liver surgery. Surgery. 2004;135:404–10.
37. Heinemann A, Wischhusen F, Puschel K, Rogiers X. Standard liver volume in the Caucasian population. Liver Transpl Surg. 1999;5:366–8.
38. Friis-Hansen B. The extracellular fluid volume in infants and children. Acta Paediatr. 1954;43:444–58.
39. Kasai H, Makuuchi M, Kawasaki S, Ishizone S, Kitahara S, Matsunami H, et al. Intraoperative color Doppler ultrasonography for partial-liver transplantation from the living donor in pediatric patients. Transplantation. 1992;54:173–5.
40. Payen DM, Fratacci MD, Dupuy P, Gatecel C, Vigouroux C, Ozier Y, et al. Portal and hepatic arterial blood flow measurements of human transplanted liver by implanted Doppler probes: interest for early complications and nutrition. Surgery. 1990;107:417–27.
41. Stevens LH, Emond JC, Piper JB, Heffron TG, Thistlethwaite JR Jr, Whitington PF, et al. Hepatic artery thrombosis in infants. A comparison of whole livers, reduced-size grafts, and grafts from living-related donors. Transplantation. 1992;53:396–9.
42. Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, et al. Risk factors for primary dysfunction after liver transplantation – a multivariate analysis. Transplantation. 1993;55:807–13.
43. Shiraishi M, Csete ME, Yasunaga C, Drazan KE, Jurim O, Cramer DV, et al. Regeneration-induced accelerated rejection in reduced-size liver grafts. Transplantation. 1994;57:336–40.
44. Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology. 1997;26:1176–81.
45. Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg. 2000;231:480–6.
46. Vauthey JN, Abdalla EK, Doherty DA, Gertsch P, Fenstermacher MJ, Loyer EM, et al. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl. 2002;8:233–40.
47. Shoup M, Gonen M, D'Angelica M, Jarnagin WR, DeMatteo RP, Schwartz LH, et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg. 2003;7:325–30.
48. Breitenstein S, Apestegui C, Petrowsky H, Clavien PA. “State of the art” in liver resection and living donor liver transplantation: a worldwide survey of 100 liver centers. World J Surg. 2009;33:797–803.
49. Ben-Haim M, Emre S, Fishbein TM, Sheiner PA, Bodian CA, Kim-Schluger L, et al. Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease. Liver Transpl. 2001;7:948–53.
50. Lo CM, Fan ST, Liu CL, Chan JK, Lam BK, Lau GK, et al. Minimum graft size for successful living donor liver transplantation. Transplantation. 1999;68:1112–6.
51. Kawasaki S, Makuuchi M, Matsunami H, Hashikura Y, Ikegami T, Nakazawa Y, et al. Living related liver transplantation in adults. Ann Surg. 1998;227:269–74.
52. Croome KP, Lee DD, Saucedo-Crespo H, Burns JM, Nguyen JH, Perry DK, et al. A novel objective method for deceased donor and recipient size matching in liver transplantation. Liver Transpl. 2015;21:1471–7.
53. Ikegami T, Shirabe K, Yoshiya S, Yoshizumi T, Yamashita Y, Harimoto N, et al. A high MELD score, combined with the presence of hepatitis C, is associated with a poor prognosis in living donor liver transplantation. Surg Today. 2014;44:233–40.
54. Marubashi S, Nagano H, Eguchi H, Wada H, Asaoka T, Tomimaru Y, et al. Minimum graft size calculated from preoperative recipient status in living donor liver transplantation. Liver Transpl. 2016;22:599–606.
55. Fukazawa K, Nishida S, Pretto EA Jr, Vater Y, Reyes JD. Detrimental graft survival of size-mismatched graft for high model for end-stage liver disease recipients in liver transplantation. J Hepatobiliary Pancreat Sci. 2016;23:406–13.
56. Allard MA, Adam R, Bucur PO, Termos S, Cunha AS, Bismuth H, et al. Posthepatectomy portal vein pressure predicts liver failure and mortality after major liver resection on noncirrhotic liver. Ann Surg. 2013;258:822–9.
57. Ogura Y, Hori T, El Moghazy WM, Yoshizawa A, Oike F, Mori A, et al. Portal pressure <15 mm Hg is a key for successful adult living donor liver transplantation utilizing smaller grafts than before. Liver Transpl. 2010;16:718–28.
58. Troisi R, Cammu G, Militerno G, De Baerdemaeker L, Decruyenaere J, Hoste E, et al. Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation? Ann Surg. 2003;237:429–36.
59. Umeda Y, Yagi T, Sadamori H, Matsukawa H, Matsuda H, Shinoura S, et al. Effects of prophylactic splenic artery modulation on portal overperfusion and liver regeneration in small-for-size graft. Transplantation. 2008;86:673–80.
60. Humar A, Beissel J, Crotteau S, Cohen M, Lake J, Payne WD. Delayed splenic artery occlusion for treatment of established small-for-size syndrome after partial liver transplantation. Liver Transpl. 2009;15:163–8.
61. Sainz-Barriga M, Scudeller L, Costa MG, de Hemptinne B, Troisi RI. Lack of a correlation between portal vein flow and pressure: toward a shared interpretation of hemodynamic stress governing inflow modulation in liver transplantation. Liver Transpl. 2011;17:836–48.
62. Boillot O, Delafosse B, Mechet I, Boucaud C, Pouyet M. Small-for-size partial liver graft in an adult recipient; a new transplant technique. Lancet. 2002;359:406–7.
63. Masetti M, Siniscalchi A, De Pietri L, Braglia V, Benedetto F, Di Cautero N, et al. Living donor liver transplantation with left liver graft. Am J Transplant. 2004;4:1713–6.
64. Takada Y, Ueda M, Ishikawa Y, Fujimoto Y, Miyauchi H, Ogura Y, et al. End-to-side portocaval shunting for a small-for-size graft in living donor liver transplantation. Liver Transpl. 2004;10:807–10.
65. Yamada T, Tanaka K, Uryuhara K, Ito K, Takada Y, Uemoto S. Selective hemi-portocaval shunt based on portal vein pressure for small-for-size graft in adult living donor liver transplantation. Am J Transplant. 2008;8:847–53.
66. Ishizaki Y, Kawasaki S, Sugo H, Yoshimoto J, Fujiwara N, Imamura H. Left lobe adult-to-adult living donor liver transplantation: Should portal inflow modulation be added? Liver Transpl. 2012;18:305–314.
67. Shimada M, Ijichi H, Yonemura Y, Harada N, Shiotani S, Ninomiya M, et al. The impact of splenectomy or splenic artery ligation on the outcome of a living donor adult liver transplantation using a left lobe graft. Hepatogastroenterology. 2004;51:625–9.
68. Fondevila C, Hessheimer AJ, Taura P, Sanchez O, Calatayud D, de Riva N, et al. Portal hyperperfusion: mechanism of injury and stimulus for regeneration in porcine small-for-size transplantation. Liver Transpl. 2010;16:364–74.
69. Wang DD, Xu Y, Zhu ZM, Tan XL, Tu YL, Han MM, et al. Should temporary extracorporeal continuous portal diversion replace meso/porta-caval shunts in “small-for-size” syndrome in porcine hepatectomy? World J Gastroenterol. 2015;21:888–96.
70. Fayed N, Refaat EK, Yassein TE, Alwaraqy M. Effect of perioperative terlipressin infusion on systemic, hepatic, and renal hemodynamics during living donor liver transplantation. J Crit Care. 2013;28:775–82.
71. Mukhtar A, Salah M, Aboulfetouh F, Obayah G, Samy M, Hassanien A, et al. The use of terlipressin during living donor liver transplantation: effects on systemic and splanchnic hemodynamics and renal function. Crit Care Med. 2011;39:1329–34.
72. Ren Z, Xu Y, Zhu S. The effect of terlipressin on hepatic hemodynamics in small-for-size livers. Hepatogastroenterology. 2012;59:208–11.
73. Fahrner R, Patsenker E, de Gottardi A, Stickel F, Montani M, Stroka D, et al. Elevated liver regeneration in response to pharmacological reduction of elevated portal venous pressure by terlipressin after partial hepatectomy. Transplantation. 2014;97:892–900.
74. Bosch J, Kravetz D, Rodes J. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Gastroenterology. 1981;80:518–25.
75. Cirera I, Feu F, Luca A, Garcia-Pagan JC, Fernandez M, Escorsell A, et al. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation. Hepatology. 1995;22:106–11.
76. Chatila R, Ferayorni L, Gupta T, Groszmann RJ. Local arterial vasoconstriction induced by octreotide in patients with cirrhosis. Hepatology. 2000;31:572–6.
77. Wiest R, Tsai MH, Groszmann RJ. Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats. Gastroenterology. 2001;120:975–83.
78. Hessheimer AJ, Escobar B, Munoz J, Flores E, Gracia-Sancho J, Taura P, et al. Somatostatin therapy protects porcine livers in small-for-size liver transplantation. Am J Transplant. 2014;14:1806–16.
79. Kume M, Hayashi T, Yuasa H, Tanaka H, Nishioka J, Ido M, et al. Bacterial lipopolysaccharide decreases thrombomodulin expression in the sinusoidal endothelial cells of rats – a possible mechanism of intrasinusoidal microthrombus formation and liver dysfunction. J Hepatol. 2003;38:9–17.
80. Kaido T, Yoshikawa A, Seto S, Yamaoka S, Furuyama H, Arii S, et al. Pretreatment with soluble thrombomodulin prevents intrasinusoidal coagulation and liver dysfunction following extensive hepatectomy in cirrhotic rats. Thromb Haemost. 1999;82:1302–6.
81. Mochida S, Arai M, Ohno A, Yamanobe F, Ishikawa K, Matsui A, et al. Deranged blood coagulation equilibrium as a factor of massive liver necrosis following endotoxin administration in partially hepatectomized rats. Hepatology. 1999;29:1532–40.
82. Nagato M, Okamoto K, Abe Y, Higure A, Yamaguchi K. Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia. Crit Care Med. 2009;37:2181–6.
83. Iba T, Nakarai E, Takayama T, Nakajima K, Sasaoka T, Ohno Y. Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model. Crit Care. 2009;13:R203.
84. Kashiwadate T, Miyagi S, Hara Y, Akamatsu Y, Kawagishi N, Sekiguchi S, et al. Recombinant human soluble thrombomodulin (ART-123) prevents warm ischemia–reperfusion injury in liver grafts from non-heart-beating donors. Transplant Proc. 2012;44:369–72.
85. Tanemura A, Kuriyama N, Azumi Y, Ohsawa I, Kishiwada M, Mizuno S, et al. Thrombomodulin administration attenuates ischemia–reperfusion injury of the remnant liver after 70% hepatectomy in rats: simulated model of small-for-size graft in living donor liver transplantation. Transplant Proc. 2014;46:1107–11.
86. Kim EY, Yoon YC. Performing a right hemihepatectomy sequentially after deceased donor liver transplantation-the solution for a large-for-size graft: a case report. Transplant Proc. 2015;47:3023–6.
87. Lemasters JJ, Bunzendahl H, Thurman RG. Preservation of the Liver. In: Maddrey WC, Schiff ER, Sorrell MF editors. Transplantation of the Liver. Philadelphia: Lippincott Williams & Wilkins; 2001.
88. Lemke AJ, Brinkmann MJ, Pascher A, Steinmüller T, Settmacher U, Neuhaus P, et al. Accuracy of the CT-estimated weight of the right hepatic lobe prior to living related liver donation (LRLD) for predicting the intraoperatively measured weight of the graft. Rofo. 2003;175:1232–8.
89. Yoshizumi T, Gondolesi GE, Bodian CA, Jeon H, Schwartz ME, Fishbein TM, et al. A simple new formula to assess liver weight. Transplant Proc. 2003;35:1415–20.
90. Taner CB, Dayangac M, Akin B, Balci D, Uraz S, Duran C, et al. Donor safety and remnant liver volume in living donor liver transplantation. Liver Transpl. 2008;14:1174–9.